• By ICR Secretariat
  • Posted Thursday, November 2, 2023

Vertex gearing up for launch as sickle cell therapy review advances


By early December, the Food and Drug Administration will decide on approval of a genetic medicine for sickle cell disease, potentially offering people with the rare blood condition a new, sought-after treatment option.